反应性蛋白不是性结肠炎的驱动因素
Zhong-Bo Ge1, Xin-Yun Zhang1, Chun-Miao Zhang1
1MOE Key Laboratory of Cell Activities and Stress Adaptations School of Life Sciences Lanzhou University, Lanzhou, Gansu 730000, China.
Gastroenterology research and practice
|October 9, 2024
概括
在小鼠中,C-反应蛋白 (CRP) 似乎不会直接引起性结肠炎. 这项研究表明,CRP可能是疾病的指标,而不是驱动因素,这需要进一步的人类研究.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 生物化学 生物化学
背景情况:
- C-反应蛋白 (CRP) 是一种不特定的炎症标志物.
- 它在性结肠炎 (UC) 进展和治疗疗效方面的作用正在调查中.
- 目前的证据缺乏强有力的支持CRP直接影响UC进步.
研究的目的:
- 调查C反应蛋白 (CRP) 在性结肠炎 (UC) 病变发生过程中的直接作用.
- 在小鼠模型中评估CRP缺乏是否影响DSS诱导的大肠炎的严重程度和进展.
主要方法:
- 使用CRP缺乏和野生型小鼠建立了硫酸 (DSS) 诱导的性结肠炎小鼠模型.
- 评估的表型参数:体重,结肠长度,脏重量.
- 评估结肠组织病理学,炎症因子表达和肠粘液层完整性.
主要成果:
- 缺乏CRP并没有显著改变DSS诱导的大肠炎的表型,生理或生化指数.
- 对控制肠道微生物群的抗生素治疗没有显示CRP缺乏小鼠的显著变化.
- 在CRP缺乏和野生类型小鼠之间,生存率是可比的.
结论:
- C-反应蛋白 (CRP) 可能不会直接调解性结肠炎.
- 在这个模型中,CRP可能是炎症的标志物,而不是引起因素.
- 由于小鼠模型的局限性,需要进一步的研究来澄清CRP在人类UC中的作用.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
147
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
147
Drugs for Treatment of Ulcerative Colitis in IBD
126
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
126
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
542
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
542
Peptic Ulcer Disease I: Introduction
141
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
141


